Point Prevalence of Lymphoedema among Cases of Lymphatic Filariasis in the Endemic District of Varanasi in India
Introduction: Lymphatic filariasis (LF) is a parasitic disease that affects millions of people worldwide. In India, LF is a priority disease for elimination; it may be neglected in some other countries. This study aimed to comprehensively analyse the prevalence, gender distribution, chronic manifestations, and age-related trends of lymphoedema and hydrocele cases reported over a four-year period.
Objective: The primary objective was to assess the prevalence of lymphoedema and hydrocele cases in this region, focusing on gender-based disparities, chronic manifestations, and age-related prevalence.
Methodology: From March 2018 to March 2022, we conducted a retrospective analysis of lymphoedema and hydrocele cases reported at the National Centre for Disease Control, Varanasi branch. Data on the total number of cases, gender distribution, and age distribution were collected and analysed using descriptive statistics.
Result: Of the 3725 lymphoedema cases reported in 4 years, the prevalence of lymphoedema was higher in males (55.2%) than females (44.8%). Chronic manifestations of this disease were observed in 66.6% and 52.7% of females and males, respectively. Age groups 31–40 and 41–50 showed the highest prevalence among patients attending the clinic.
Conclusion: Our findings show that a significant burden of lymphoedema cases of lymphatic filariasis are prevalent in the endemic district of Varanasi, and most of them are chronic and older cases where this disease is hampering the quality of life. The findings emphasise the importance of tailored interventions that consider gender, chronicity, and age-related factors in addressing the burden of lymphatic filariasis-related conditions.
How to cite this article:
Baskar V, Dwivedi A, Yadav AK, Anjum Z, Garg S, Garg VK, Goel A. Point Prevalence of Lymphoedema among Cases of Lymphatic Filariasis in the Endemic District of Varanasi in India. XIV Annual Conference of Indian Society for Malaria & Other Communicable Diseases (ISMOCD). 2023;71-74.
World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2021. No 41. Wkly Epidemiol Rec. 2022;97:513-24. [Google Scholar]
Ministry of Health and Family Welfare, Government of India [Internet]. Union Minister for Health and Family Welfare, Dr Mansukh Mandaviya chairs National Symposium on India’s roadmap to eliminate lymphatic filariasis (LF); [cited]. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1890935
National Vector Borne Disease Control Programme, National Health Mission. VL/LF update. Newsletter for visceral leishmaniasis (VL) and lymphatic filariasis (LF). 2nd ed. NVBDCP; 2022;4(4).
Kamal S, Chandra R, Singh SM, Kumar A, Mittra KK, Roy N. Mass drug administration (MDA) for lymphatic filariasis elimination in Uttar Pradesh, India: issues, gaps & challenges. J Commun Dis. 2020;52(3):62-73. [Google Scholar]
Mutheneni SN, Upadhyayula SM, Kumaraswamy S, Kadiri MR, Nagalla B. Impact of socioeconomic factors on the prevalence of lymphatic filariasis in Andhra Pradesh, India. J Public Health. 2015;23:231-40. [Google Scholar]
Sabesan S, Raju KH, Subramanian S, Srivastava PK, Jambulingam P. Lymphatic filariasis transmission risk map of India, based on a geo-environmental risk model. Vector Borne Zoonotic Dis. 2013;13(9):657-65. [PubMed] [Google Scholar]
Ramaiah KD, Ramu K, Kumar KN, Guyatt H. Epidemiology of acute filarial episodes caused by Wuchereria bancrofti infection in two rural villages in Tamil Nadu, south India. Trans R Soc Trop Med Hyg. 1996;90(6):639-43. [PubMed] [Google Scholar]
Sharma S, Sharma M, Rathaur S. Bancroftian filariasis in the Varanasi region of north India: an epidemiological study. Ann Trop Med Parasitol. 1999;93(4):379-87. [PubMed] [Google Scholar]
Pani SP, Balakrishnan N, Srividya A, Bundy DA, Grenfell BT. Clinical epidemiology of bancroftian filariasis: effect of age and gender. Trans R Soc Trop Med Hyg. 1991;85(2):260-4. [PubMed] [Google Scholar]
Copyright (c) 2023 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.